Guest guest Posted April 27, 2005 Report Share Posted April 27, 2005 Don't you suppose a big reason CFS isn't being aggressively studied is that it is probably a morass of several different disorders which complicate and aggravate one another . . . so the chances are low of a researcher achieving a " silver bullet " success leading to the development of a " killer drug " which makes some Big Pharma Co a lot of money? Researchers have careers to think about. They need successful projects which lead to marketable drugs to get ahead in their world. CFS is not the place to come looking for that. CFS is too hard, too complex for Big Pharma's money. Jan Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.